SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Direxion Shares ETF Trust - Direxion Daily Homebuilders & Supplies Bull 3X Shares

Direxion Daily Homebuilders & Supplies Bull 3X Shares

The Direxion Daily Homebuilders & Supplies Bull 3X Shares ($NAIL) is trending amid discussions about potential interest rate cuts and their impact on the housing market. Community members are weighing the possibility of a new housing bubble and debating the ETF's future trajectory, with some pointing to technical indicators suggesting a buying opportunity. Recent data on pending home sales and building permits are also factoring into the conversation.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending following positive Phase 1 data for its CTX310 therapy, showcasing significant cholesterol and triglyceride reduction with a one-time treatment. The community is excited about the potential for a single-dose solution to lifelong lipid disorders, with some anticipating blockbuster potential and future applications in diabetes and cancer.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

$SLAP is gaining attention, with community members expressing excitement and anticipation for potential gains. Sentiment revolves around the project's progress and future prospects, particularly within the Base network. The community frequently uses the terms '$BROKE', '$RAGE', and '$WAGMI', potentially indicating a shared experience of overcoming challenges and striving for success.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending amid speculation of a potential Netflix bid for its studio and streaming business, intensifying an existing acquisition buzz. Community chatter revolves around potential bidding wars and deal valuations, with some highlighting WBD's valuable IP while others are skeptical of its debt.  Comcast and Paramount/Skydance remain in the mix as possible suitors.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

CVM is trending amid anticipation for a decision from the Saudi Food and Drug Authority (SFDA) regarding Breakthrough Medicine Designation for Multikine. Community discussions revolve around the potential for expedited approval and market access in Saudi Arabia, a key element of CEL-SCI's strategic roadmap. Some are expressing frustration from the long wait time, while others remain confident in the drug's potential and the partnership with Dallah Pharma.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending amid community speculation about future developments like smart contracts and Layer 2 solutions, with some drawing comparisons to Bitcoin's roadmap and anticipating ETF impacts. Bullish investors are highlighting Litecoin's historical role and potential for adoption, while others express frustration with its past performance and caution against short-term pumps.

Monero

Monero is trending as community members discuss its potential, use cases, and status as a leading privacy coin. Recent price action and bullish chart patterns have sparked speculation about Monero's future, with some eyeing previous all-time highs, while others believe it is what Bitcoin should have been. The community is also discussing its relative stability compared to other cryptocurrencies and its importance in a world where privacy is increasingly valued.

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation, analytics and reports, revenue cycle, patient surveys, and privacy and security products. Its solutions include health systems, multi-specialty, and federally qualified health centers (FQHCs). The company was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in Wilmington, DE.

Phreesia Inc

Shares of Phreesia Inc ($PHR) are seeing increased attention, potentially due to the company's consistent revenue growth and expansion via the acquisition of AccessOne, which is projected to boost revenue and TAM. Bullish analysts are pointing to the company's AI initiatives and potential for advertising revenue growth as additional catalysts. The community is debating the stock's valuation and market maker influence.

ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF

Biotech stocks are rallying, with $BBC hitting a 52-week high, as optimism around regulatory approvals, potential rate cuts, and attractive valuations fuel sector-wide momentum. Community members are noting new highs and large volume, while also cautioning appropriate position sizing given the volatility of binary events. The ETF's positive weighted alpha and sector tailwinds are also key discussion points.

CLV is a one-stop infrastructure platform for cross-chain and decentralized applications. The CLV chain is a Substrate-based specialized Layer-1 chain that is EVM compatible, cross-chain interoperable, and also functions as a Parachain in the Polkadot ecosystem. CLV wallet is a cross-chain all-in-one wallet, for Day-to-Day, DeFi, Metaverse and Gaming purposes. With multi-dimensional products lineup, including CLV Multi-Chain Wallets, CLV dApp Interaction Protocol, CLV Chain EVM and Universal Cross-Chain Support, CLV uniquely positioned itself as “Passport to the Omniverse.”

Clover 

Clover Finance ($CLV) is trending with community members actively discussing its potential for a breakout, possibly fueled by accumulation patterns and upcoming developments. Bullish sentiment seems to be driven by technical analysis suggesting a shift from accumulation to breakout mode, with some eyeing targets based on prior price levels. However, some traders express frustration with the token's performance and refer to it as a scam.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LightPath Technologies (NASDAQ:LPTH) Share Price Passes Above 200 Day Moving Average - Time to Sell?

LightPath Technologies (NASDAQ:LPTH) Stock Crosses Above Two Hundred Day Moving Average - Here's Why...

Universal Display Corp. (OLED) Lags Q3 Earnings and Revenue Estimates

Universal Display (OLED) delivered earnings and revenue surprises of -22.69% and -14.09%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Allient (ALNT) Q3 Earnings and Revenues Surpass Estimates

Allient (ALNT) delivered earnings and revenue surprises of +18.00% and +3.02%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

LightPath Technologies to Host First Quarter Fiscal 2026 Earnings Call on November 11 at 5:00 p.m. Eastern Time

LightPath Technologies to Host First Quarter Fiscal 2026 Earnings Call on November 11 at 5:00 p.m. Eastern Time LightPath Technologies to Host First Quarter Fiscal 2026 Earnings Call on November 11...

Novanta (NOVT) Surpasses Q3 Earnings and Revenue Estimates

Novanta (NOVT) delivered earnings and revenue surprises of +7.41% and +0.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

LightPath Technologies Appoints Defense Industry Executive Mark Caylor to Board of Directors

LightPath Technologies Appoints Defense Industry Executive Mark Caylor to Board of Directors LightPath Technologies Appoints Defense Industry Executive Mark Caylor to Board of Directors PR Newswire...

Lightpath Technologies’ (LPTH) stock fell nearly 3% in extended trading on Thursday after the optics and imaging systems provider posted a wider loss in the fiscal fourth quarter.The Orlando, Florida-based company reported a net loss of $7.1 million, or $0.16 per share, for the quarter ended June 30, compared to a loss of $2.4 million, or $0.06 per share, in the same quarter of the prior fiscal year.The loss widened primarily due to its acquisition of New Hampshire-based G5 Infrared, which it bought for $27 million in February. The G5 business specializes in long-range mission-critical detection solutions, focusing on defense, border security, and counter-drone markets.However, the company’s revenue increased to $12.2 million, compared to $8.6 million in the fourth quarter of the previous year. Its revenue was also in line with analyst estimates, according to Fiscal.ai data. Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/LPTH">Lightpath</a> still moved into ‘bullish’ territory, compared with ‘neutral’ a day ago.<figure class="image"><img style="aspect-ratio:793/99;" src="https://news.stocktwits-cdn.com/LPTH_Sept_25_JPG_c348e585ca.webp" alt="LPTH’s Sentiment Meter and Message Volume as of 10:35 p.m. ET on Sept. 25, 2025 | Source: Stocktwits" width="793" height="99"><figcaption>LPTH’s Sentiment Meter and Message Volume as of 10:35 p.m. ET on Sept. 25, 2025 | Source: Stocktwits</figcaption></figure>Lightpath has invested heavily in developing proprietary technologies, including black diamond glass, which is free of germanium, a mineral primarily supplied from China. Beijing slapped export restrictions on the mineral in December last year amid ongoing trade tensions with the U.S.“Our backlog today is around $90 million. That is more than 4x what the backlog was just a few months ago. And with more than 2/3 of this backlog in systems and subsystems,” CEO Sam Rubin said.“Not happy with the margins this [quarter] they just reported, but that's headed higher going forward as they explained and will be profitable starting [in the] second half of next year,” one user said.<stembedurl>https://stocktwits.com/DiscoDave69/message/630059316</stembedurl>The stock has risen over 80% this year. Earlier this month, Lightpath received $8 million in strategic investment from emerging defense industry players Ondas and Unusual Machines.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/trump-shocks-pharma-with-100-tariff-on-imported-drugs-unless-companies-build-in-america/chDVGpjR3I2">Trump Shocks Pharma With 100% Tariff On Imported Drugs Unless Companies Build In America</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, graph on a trader's computer screen, representing the concept of trading financial instruments. (Photo Illustration by Roberto Machado Noa/LightRocket via Getty Images)

Why Did Lightpath Technologies' Stock Fall After-Hours Today?

The infrared solutions provider’s loss widened primarily due to its acquisition of New Hampshire-based G5 Infrared, which it bought for $27 million in February.

Equity

LightPath Technologies, Inc. (LPTH) Reports Q3 Loss, Misses Revenue Estimates

Allient (ALNT) Q1 Earnings and Revenues Top Estimates

LightPath Technologies Announces Closing of Acquisition of G5 Infrared LLC

LightPath Technologies Announces Closing of Acquisition of G5 Infrared LLC LightPath Technologies Announces Closing of Acquisition of G5 Infrared LLC PR Newswire ORLANDO, Fla., Feb. 19, 2025 ORLANDO...

This account has been verified as an official LPTH representative.

Verified Account

LightPath Technologies

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

LPTH
Lightpath Technologies, Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LPTH News

LPTHLightpath Technologies, Inc. - Ordinary Shares - Class A